AU703344B2 - Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface - Google Patents

Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface Download PDF

Info

Publication number
AU703344B2
AU703344B2 AU34103/95A AU3410395A AU703344B2 AU 703344 B2 AU703344 B2 AU 703344B2 AU 34103/95 A AU34103/95 A AU 34103/95A AU 3410395 A AU3410395 A AU 3410395A AU 703344 B2 AU703344 B2 AU 703344B2
Authority
AU
Australia
Prior art keywords
dna
nucleic acid
biosensor
film
electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU34103/95A
Other versions
AU3410395A (en
Inventor
Allen J Bard
Xiao-Hong Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IGEN International Inc
Original Assignee
IGEN International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IGEN International Inc filed Critical IGEN International Inc
Publication of AU3410395A publication Critical patent/AU3410395A/en
Assigned to IGEN INTERNATIONAL, INC. reassignment IGEN INTERNATIONAL, INC. Alteration of Name(s) of Applicant(s) under S113 Assignors: IGEN, INC.
Application granted granted Critical
Publication of AU703344B2 publication Critical patent/AU703344B2/en
Priority to AU36767/99A priority Critical patent/AU3676799A/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/001Enzyme electrodes
    • C12Q1/005Enzyme electrodes involving specific analytes or enzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • C12Q1/6825Nucleic acid detection involving sensors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing

Description

WO 96/06946 PCT/US95/10630 Title of the Invention BIOSENSOR FOR AND METHOD OF ELECTROGENERATED CHEMILUMINESCENT DETECTION OF NUCLEIC ACID ADSORBED TO A SOLID SURFACE Field Of Invention The present invention relates to the diagnostic field, and especially nucleic acid diagnostics. In particular, the present invention relates to a probe or sensor having a film containing metal centers, its preparation where a single-strand or double-strand nucleic acid sequence is immobilized thereon on, and its use in the subsequent detection of the nucleic acid by labelling with luminescent metal chelates.
In addition to using the subject biosensor for nucleic acid diagnostics based on a surface designed modified electrical sensor, chips or electrode, immobilization and hybridization of nucleic acid such as DNA on a selfassembled thin film via surface reaction is also useful in studying molecular recognition of DNA.
Background Of Invention Nucleic acid diagnostics has become an important area in molecular biology and biotechnology studies, with applications to the determinations of disease and food contaminating organisms and in forensic and environmental investigations. The development of new DNA biosensors has led to the application of several detection techniques such as WO 96/06946 PCTUS95/10630 optical methods luminescence, ellipsometry and pseudo- Brewster angle reflectometry), piezoelectric devices SAW, QCM), and electrochemical techniques CV and SWV).
Of particular interest are labels which can be made to luminesce through photochemical, chemical, and electrochemical reaction schemes. In particular, electrochemiluminescent methods of determining the presence of labelled materials are preferred over other methods for many reasons. They are highly diagnostic of the presence of a particular label, sensitive, nonhazardous, inexpensive and can be used in a wide variety of applications. Suitable labels comprise electrochemiluminescent compounds, including organic compounds and metal chelates.
For example, electrochemiluminescent ruthenium- and osmium-containing labels have been used in methods for detecting and quantifying analytes of interest in liquid media Patent Nos. 5,310,687; 5,238,808; and 5,221,605). In addition, the application of electrogenerated chemiluminescence (ECL) measurements to the detection of solution phase DNA intercalated with ruthenium-containing labels has been described (Carter, M.T. et al. (1990) Bioconjugate Chem 2:257-263). However, reaction schemes that are viable in the solution phase are often not applicable in the solid phase.
More importantly, the detection of solution phase analytes such as DNA has several drawbacks relative to detection of analytes absorbed to solid surfaces. The advantages for detecting DNA via solid phase techniques as opposed to -2- WO 96/06946 PCTUS95/10630 solution techniques are: more sensitive (detection of monolayer quantities); easier to separate DNA from sample (avoid interferences); and possibility of detection of several different DNA in single analysis, with localized probes, as in sequencing studies.
These luminescent systems are of increasing importance in diagnostics. For example, in U.S. Pat. No.
4,372,745, chemiluminescent labels are used in immunochemical applications where the labels are excited into a luminescent state by reaction of the label with H202 and an oxalate. In these systems, H202 oxidatively converts the oxalate into a high energy derivative, which then excites the label. It is expected, that in principle, the H 2 0 2 and an oxalate reaction scheme should work with any luminescent material that is stable under the oxidizing conditions of the assay, and can be excited by the high energy oxalate derivative. Unfortunately, this very versatility is a major drawback of the 4,372,745 patent: lack of selectivity or specificity, typical biological fluids containing the analyte of interest also contain a large number of potentially luminescent substances that can cause high background levels of luminescence.
Thus a need exists for a solid phase system, a biosensor, and method that provides the necessary specificity absent systems that rely on the H 2 0 2 and oxalate reaction scheme; and do not depend on solution techniques.
The present invention overcomes the limitations and drawbacks -3- WO 96/06946 PCT/US95/10630 of the prior art.
Summary Of Invention The present invention provides a biosensor and its use for electrogenerated chemiluminescent detection of nucleic acid absorbed to a solid surface via the use of ruthenium- and osmium-containing chemiluminescent labels.
An object of the present invention is to provide a film containing an aluminum (III) alkanebisphosphonate layer having metallic aluminum centers, ionic aluminum Al(III) centers, for bonding to single-strand or double-strand DNA immobilized to said aluminum centers. The aluminum (III) alkanebisphosphonate can be provided as a biosensor having a coating of A1 2
(C
4 BP) to bond to SS-DNA or ds-DNA.
A further object of the present invention is to provide a biosensor in the form of chips or electrodes with adsorbed DNA that is labelled with a luminescent label, such as an osmium or ruthenium moiety.
A still further object of the present invention is to prepare a biosensor by treating a silicon wafer to form a chromium layer and juxtaposed gold layer, then contacting the layered wafer with an anchoring agent; and subsequently immersing the product in A1(N0 3 3 bisphosphonic acid
(H
2 0 3
P(CH
2 4
PO
3
H
2 and Al(N0 3 3 aqueous solutions.
Another object of the present invention involves the detection of a nucleic acid by labelling with luminescent metal chelates.
-4- A further object of the present invention is to apply electrogenerated chemiluminescent techniques to a plurality, arrayed, oligonucleotide probes.
These and other objects will become more apparent from the following detailed description and drawings.
According to a first embodiment of the invention there is provided a method of detecting nucleic acids comprising: a. forming a sensor surface bearing a film having metallic centres; b. adsorbing at least one nucleic acid onto to said metal centres; c. reacting nucleic acid adsorbed to said film with a luminescent metal label; and d. detecting the nucleic acid metal label chelates formed in step via electrogenerated chemiluminescence of said chelates.
According to a second embodiment of the invention there is provided a method of detecting nucleic acids comprising: 15 a. forming an electrode by adsorbing at least one nucleic acid onto said electrode; b. reacting nucleic acid adsorbed to said electrode with a luminescent label; and c. detecting the nucleic acid label formed in step via electrogenerated 20 chemiluminescence.
According to a third embodiment of the invention there is provided an aluminum alkanebisphosphonate biosensor comprising: a substrate and a first metallic layer; and an aluminum alkanebisphosphnate layer forming (Al) metallic centres.
According to a fourth embodiment of the invention there is provided a method of preparing a biosensor for nucleic acid, comprising: o 44 a) treating a silicon wafer to form a chromium layer and juxtaposed gold layer; b) contacting said layered wafer with an anchoring agent; and c) immersing the product of step b) alternately in Al(NO 3 3 bisphosphonic 3
P(CH
2 4 P0 3
H
2 and Al(N0 3 3 aqueous solutions.
According to a fifth embodiment of the invention there is provided a biosensor comprising: an electrode substrate, adsorbed ss-DNA or ds-DNA immobilised on said electrode, and a detectable label on said ss-DNA or ds-DNA, wherein the detectable label is capable of being oxidised or reduced.
Brief Description of the Drawings Fig. 1 shows a schematic representation of the silicon electrode of the present nvention containing ionic aluminum Al (III) sites.
[N:\LIBFF10348:SAK Fig. 2 shows immobilisation of ds-DNA on a A1 2
(C
4 BP) film and interaction of Ru(phen) 3 2 with the ds-DNA.
Figs. 3A-3C show first second and third scans. ECL emissionpotential transients at the A1 2
(C
4 BP)/DNA-Ru(phen) 3 2 electrode in 0.19 M phosphate buffer, pH 7, containing 0.13 M TPrA. (Scanning was halted and the solution stirred after each scan). Scans were initiated at 0 V and were directed toward more positive potentials. Scan rate, 50 mV/s.
Figs. 4A-4C show schematic representations of immobilisation of ss-DNA tagged with Ru(bpy) 3 2 on the film (Fig. 4A); immobilisation of ss-DNA on the film and hybridisation of complementary strand DNA a 0*
O
ft Clal [N:\LIBFF]0348:SAK WO 96/06946 PCTUS95nO630 tagged with Ru(bpy) 3 2 (Fig. 4B); immobilization of poly(dA) on the film, hybridization of poly(dT), and then interaction of Ru(phen) 3 2 with the ds- DNA(poly(dA)*poly(dT)) where the represents an ECL active species.
Figures 5A-5C show a cyclic voltammogram (Fig. an emission-potential transient of the Al2(C 4 BP)/ -1 ss-DNA-Ru(bpy) 3 2 electrode in 0.19 M phosphate buffer/0.13 M TPrA, pH 7 (Fig. 5B); and an emission-potential transient of the Al 2
(C
4 BP)X-1 ss-DNA in the same solution (Fig. 5C). The electrode used in the experiments shown in Figures 5A-5C was prepared as described in the specification with immersion in a 1.38 gM X-1 ss-DNA-Ru(bpy) 3 or X-1 ss-DNA solution for -4 h, respectively. In each case, the potential was scanned from 0 to 1.60 V at v 50 mV/s.
Figure 6 shows an emission-time transient for the Al 2
(C
4 BP)/X-i ss-DNA-Ru(bpy) 3 2 electrode in 0.19 M phosphate buffer/0.13 M TPrA, pH 7, when the potential was stepped from 0 to 1.5 V.
Figures 7A and 7B show ECL emission-potential transients at the A1 2
(C
4 BP)/\-lc ss-DNA/X-l -6- WO 96/06946 PCT/US95/10630 ss-DNA-Ru(bpy) 3 2 electrode (Fig. 7A) and at the A1 2
(C
4 BP)/X-1 ss-DNA/X-1 ss-DNA- Ru(bpy) 3 2 electrode (Fig. 7B) where both electrodes are immersed in 0.19 M phosphate buffer, pH 7, containing 0.13 M TPrA and the potential was scanned from 0 to 1.60 at scan rate, 50 Mv/s.
Figures 8A and 8B show ECL emission-potential transients at the A1 2
(C
4 BP)/poly(dA)/poly(dT)/Ru(phen) 3 2 electrode (Fig. 8A) and at the Al 2
(C
4 BP) /poly(dA) /Ru(phen) 3 2+ electrode (Fig. 8B) where both electrodes are immersed in 0.19 M phosphate buffer, pH 7, containing 0.13 M TPrA, and the potential was scanned from 0 to 1.60 at scan rate, mV/s.
Figures 9A-9C show TEM images of Au substrate coated on a Formvar film on a #400 Cu grid (Fig.
9A); the A12(C 4 BP) film on the Au substrate (Fig. 9B); immobilized calf thymus ds-DNA on the A1 2
(C
4 BP) film, prepared by immersing the film in a 1.65 mM [NP] of ds-DNA solution for 4 h (Fig. 9C).
Figures 10A-10C show TEM images of the Al1(C 4
BP)
film on Au substrate coated on a Formvar film (Fig. 10A); immobilized calf thymus WO 96/06946 PCTIUS95/10630 ds-DNA on the A1 2
(C
4 BP) film, prepared by immersing the film in a 1.65 mM [NP] of ds-DNA solution, for -4 h (Fig. immobilized sonicated calf thymus ds-DNA on the A1 2
(C
4 BP) film, prepared by immersing the film in a 1.65 mM [NP] of ds-DNA solution, sonicated for -6 h at room-temperature, for -4 h. (Fig. Figures 11A 11B show sequencing via array hybridization.
Detailed Description Of Invention The present invention relates to a sensor and method of detecting nucleic acids using the sensor. The sensor can be a chip, electrode, or an appropriately modified surface for adsorbing ss-DNA or ds-DNA. The nucleic acids detected by the method of the present invention include DNA, cDNA or any synthetic variant thereof. A nucleic acid as used throughout the specification and in the claims is meant DNA or any synthetic variant thereof.
Examples of DNAs detectable by the present method include chromosome DNA, plasmid DNA, viral DNA, bacterial DNA and recombinant DNA. The length of nucleic acid sequence capable of detection by the present method ranges from about 2.7 nm to about 200 nm. In a preferred embodiment, the nucleic acid sequence ranges from 8 base pair (bp) nucleotides to 3,000 base pair nucleotides. In a most -8- WO 96/06946 PCT/US95/10630 preferred embodiment ranges from about 30 bp nucleotides to 1,500 bp nucleotides.
In the present invention, the nucleic acid sequence to be detected may be of purified nucleic acid or may be present in a biological sample. Biological samples in which nucleic acids can be detected using the method of the present invention include but are not limited to biological fluids, serum, saliva, hair, skin, etc. Alternatively, the nucleic acid can be purified from a sample using methods known to those skilled in the art (Current Protocols in Electrobiology (1994 ed. Ausubel, F.M. et al. John Wiley Sons, Inc.)).
The aluminum (III) alkanebisphosphonate preferably used is a A1 2
(C
4 BP), also [A1 2
C
4 BP], film bearing biosensor and is prepared as follows. Silicon wafers were soaked in trichloroethylene for 30 min, rinsed twice with 2-propanol, rinsed with excess amount of deionized water, and then dried with a stream of dry nitrogen. The clean silicon wafers were primed with a 50 A chromium layer followed by deposition of a 2000 A gold layer. Chromium and gold targets (99.999%) were used to sputter the films onto the wafers in a MRC Model 8620 system at 102 torr. Other techniques, such as chemical vapor deposition (CVD) to apply the Au or Cr layers, can also be used.
The gold surface supported on the silicon wafers was cleaned with hot chromic acid (saturated KCr 2
O
7 in 90% H 2
SO
4 for -10 s and then rinsed with copious amounts of water. This -9- WO 96/06946 PCT/US95/10630 process was repeated until the surface contact angle with water was less than 150. The clean Au surface was then immediately soaked in an anchoring agent, 0.5 mM 4mercaptobutylphosphonic acid (MBPA) solution in absolute ethanol for -24 h. See Fig. 1. The phosphoric acid terminated surface was then thoroughly rinsed with the ethanol, dried with a stream of N 2 and then immersed alternately in 5 mM Al(N0 3 3 5 mM bisphosphonic acid
(H
2 0 3
P(CH
2 4
PO
3
H
2 and 5 mM Al(N0 3 3 aqueous solution, taking -4 h for each immersion, with washing with water between each step.
Although the preferred embodiment contemplates the use of Al centers, other metal centers, such as, lanthanum (La) and zirconium (Zr) are also contemplated. In addition, although a
C
4 specie was utilized in producing the alkanebisphosphonate film, other chain links, C 2
-C
6 may be utilized, which result in adequate spacing of the aluminum ions on the surface of the film to permit contact with the phosphates of the DNA backbone. In other words, the "spacer" may range from 2 to 16 carbons in length.
The sensor described above is used by: a) adsorbing a nucleic acid onto a film containing metal centers; b) reacting nucleic acid adsorbed to said film with a luminescent metal label; and c) detecting the nucleic acid metal label chelates formed in step b) via electrogenerated chemiluminescence of said chelates.
WO 96/06946 PCT/US95/10630 In step the film to which the nucleic acid is adsorbed should contain metal ions which are suitably spaced on the surface of the film to allow interaction of the metal with the phosphate backbone of the nucleic acid sequence.
Examples of metal centers suitable for use in binding to nucleic acid phosphate groups are aluminum, lanthanum, and zirconium. In a preferred embodiment, the film contains an aluminum Al (III) metal center.
The nucleic acid adsorbed to the film in step of the method of the present invention may be either doublestranded or single-stranded. When a single-stranded nucleic acid is adsorbed to the film, the adsorbed single-stranded nucleic acid is then hybridized to a complementary singlestranded nucleic acid sequence. Conditions of hybridization are utilized which promote base pairing between the singlestranded DNA adsorbed to the film in its complementary sequence. Factors influencing hybridization between nucleic acid sequences are known to those skilled in the art and include salt concentration of the hybridization solution, hybridization temperature and stringency of post-hybridization washes. In addition, the length of hybridization may also be controlled to optimize binding. Satiable buffers in which to carry out the hybridization reaction include 5mM Tris buffer, pH 7 containing 50 mM NaCl.
The complementary single-stranded nucleic acid sequence hybridized with the nucleic acid adsorbed to the film may be unlabeled or labeled with a luminescent metal label.
-11- WO 96/06946 PCT/US95/10630 Suitable luminescent labels include ruthenium- and osmiumcontaining labels where ruthenium or osmium are bound to at least one polydentate ligand. If the metal has greater than one polydentate ligand, the polydentate ligands may be the same or different. (Other known ECL active labels can-also be utilized that emit at different wave lengths such as organic ECL labels, e.g. sulfonated-9,10-diphenylanthracene.) Polydentate ligands of either ruthenium or osmium include aromatic and aliphatic ligands. Suitable aromatic polydentate ligands include aromatic heterocyclic ligands. Preferred aromatic heterocyclic ligands are nitrogen-containing, such as, for example, bipyridyl, bipyrazyl, terpyridyl, and phenanthrolyl. If the metal chelate has greater than one polydentate ligand, the polydentate ligands may be the same or different.
Suitable polydentate ligands may be unsubstituted, or substituted by any of a large number of substituents known to the art. Suitable substituents include for example, alkyl, substituted alkyl, aryl, substituted aryl, aralkyl, substituted aralkyl, carboxylate, carboxaldehyde, carboxamide, cyano, amino, hydroxy, imino, hydroxycarbonyl, aminocarbonyl, amidine, guanidinium, ureide, sulfur-containing groups, phosphorous containing groups, and the carboxylate ester of Nhydroxysuccinimide.
The ruthenium or osmium may have one or more monodentate ligands, a wide variety of which are known to the art. Suitable monodentate ligands include, for example, -12- WO 96/06946 PCT/US95/10630 carbon monoxide, cyanides, isocyanides, halides, and aliphatic, aromatic and heterocyclic phosphines, amines, stibines, and arsines. A more complete list of the ligands, monodentate and polydentate ligands, that can be used in the present invention are set forth in U.S. Patent Nos.
5,310,687, 5,238,808 and 5,221,605, the subject matter of which are incorporated herein by reference.
It is also within the scope of this invention for one or more of the ligands of the metal to be attached to additional chemical labels, such as, for example, radioactive isotopes, fluorescent compounds, or additional luminescent ruthenium- or osmium-containing centers.
The complementary single-stranded nucleic acid may be tagged with the preferred luminescent metal labels of the present invention via co-valent bonding to one or more of the polydentate ligands of the metal label through one more amide linkages. This linkage may be oriented so that the nucleic acid is bonded directly either to the carbinol or to the nitrogen of the amide linkage. These chemical moieties may be ionized. A more elaborate description of methods for attaching a luminescent ruthenium-containing or osmiumcontaining label to amino groups of biological substances such as nucleic acid is provided in U.S. Patent No. 5,221,605 incorporated by reference.
In an alternative embodiment, the complementary single-stranded nucleic acid is unlabeled and hence, hybridization to a single-stranded nucleic acid adsorbed to a -13-
I
WO 96/06946 PCT/US95/10630 film results in generation of unlabeled double-stranded nucleic acid adsorbed to the film. Thus, double-stranded nucleic acid can be adsorbed to the film directly or can be created by first adsorbing single-stranded nucleic acid to the film and then hybridizing the adsorbed nucleic acid with its complementary sequence. In either case, the film containing the adsorbed double-stranded nucleic acid is then immersed in a solution containing luminescent metal label or a solution suitable for promoting intercalation of the metal with the double-stranded nucleic acid. Examples of suitable solutions include, but are not limited to water.
A nucleic acid in which the luminescent metal containing labels intercalates to produce nucleic acid--metal label chelates is then detected by inducing the metal label present in the chelates to emit electromagnetic radiation by creating an excited state of the metal species that will luminesce at wave lengths from about 200 nanometers to about 900 nanometers, at ambient temperatures. Intercalation (or more generally, association) of the ECL labeled species with DNA depends upon the experimental conditions in which the label is partially inserted between the base pairs of DNA. It is considered "association" because of an electrostatic interaction between a positively-charged label and the negatively-charged phosphate groups on the DNA. The exact nature of the interaction of Ru(phen) 3 2 with DNA is uncertain, but is believed to be intercalation. The temperature must be below the melting point of ds-DNA, preferably about 25-300 C.
-14- WO 96/06946 PCT/US95/10630 The pH is typically near 7, but within a range of about 5 to about 8. The intercalation or association reaction must be given sufficient time to occur; about 30 to about 60 minutes, although times as short as 10 minutes also work.
In one embodiment of the present invention, the metal label is excited by exposing the nucleic acid-metal label chelates to electrochemical energy. The potential at which the oxidation of the metal label will occur depends upon the exact structure of the metal label as well as factors such as the co-reactant utilized, the pH of the solution and the nature of the electrode used. Examples of suitable coreactants which, when incubated with the nucleic acid-metal label chelates in the presence of the electrochemical energy, will result in emission of the metal label intercalated with the nucleic acid, include tripropylamine (TPrA), oxalate or other organic acid such as pyruvate, lactate, malonate, tartrate and citrate. This oxidation can also be performed chemically, with some strong oxidants such as PbO, or a Ce(IV) salt.
Those of ordinary skill in the art recognize how to determine the optimal potential and emission wave length of an electrochemiluminescent system. The electrochemiluminescent species may be measured by any suitable mechanism such as measurement of an electric current or emitted electromagnetic radiation. For example, the rate of energy inputted into the system can provide a measure of the luminescent species.
Suitable measurements include, for example, measurements of WO 96/06946 PCT/US95/10630 electric current when the luminescent species is generated electrochemically, the rate of reductant or oxidant utilization when the luminescent species is generated chemically or the absorption of electromagnetic energy in photoluminescent techniques. In addition, of course, the luminescent species can be detected by measuring the emitted electromagnetic radiation. All of these measurements can be made either as continuous, rate-based measurements, or as cumulative methods which accumulate the signal over a long period of time. An example of rate-based measurements would be by using photomultiplier tubes, photodiodes or phototransistors to produce electric currents proportional in magnitude to the incident light intensity. Examples of cumulative methods are the integration of rate-based data, and the use of photographic film to provide cumulative data directly.
All of these luminescence-based methods entail repeated luminescence by the ruthenium-containing compound.
The repetitive nature of the detectable event distinguishes these labels from radioactive isotopes or bound chemiluminescent molecules such as luminol. The latter labels produce a detectable event only once per molecule (or atom) of label, thereby limiting their detectability.
The following examples illustrate various aspects of the invention but are in no way intended to limit the scope thereof. Analysis was performed in a Plexiglas cell designed for ECL and electrochemical studies using the film of the -16- WO 96/06946 PCT/US95/10630 present invention, a gold surface supported on the silicon wafer containing metallic sites, Al. A saturated calomel reference electrode (SCE) and a platinum wire counter electrode were used for all measurements. The electrochemical measurements coupled with ECL experiments were carried out with a Model 175 universal programmer, a Model 173 potentiostat (Princeton Applied Research, PAR, Princeton,
NJ),
and an Ominigraphic 2000 X-Y recorder (Houston Instruments, Houston, TX). The ECL emission was detected by a Model C123 single-photon-counting system (Hamamatsu Corp., Bridgewater, NJ) utilizing a Hamamatsu R928P PMT, cooled to -20 0 C in a Model TE 308 TSRF cooler controller (Products for Research Inc., Danvers, MA). The meter output was fed into the y-axis of the x-y recorder, and the signal from the potentiostat was fed into the x-axis to afford ECL intensity versus bias potential display. Solution analysis by ECL was carried out with a QPCR analyzer (Perkin-Elmer, Norwalk, CT).
A MRC (Materials Research Corporation, Orangeburg, NY) Model 8620 sputtering system at 10- 2 torr, with an RF power of 150 W and RF peak to peak voltage of 1.8 KV, was used to sputter gold (99.999%) on silicon wafers.
Polydeoxyadenylic acid (Poly(dA)), polythymidylic acid (poly(dT), polydeoxycytidylic acid (poly(dC)) and calf thymus (CT) ss-DNA and ds-DNA were obtained from Sigma Chemical Co. (St. Louis, MO) and were used without additional purification. The ss-DNA samples, X-l DNA (5'GAAAATGTGCTGACCGGACATGAAAATGAG3'), (Seq. ID. No. 1) X DNA -17- WO 96/06946 PCT/US95/10630 tagged with Ru(bpy) 3 2 +(5'Ru(bpy) 3 2+- GAAAATGTGCTGACCGGACATGAAAATGAG3'), (Seq. ID. No. 2) and a complementary strand X-lc DNA (5'CTCATTTTCATGTCCGGTCAGCACATTTTC3'), were obtained from Perkin-Elmer and diluted with a 5 mM tris buffer containing mM NaCl(pH Synthesis of ss-DNA can be carried out on a DNA synthesizer Applied Biosystems, Model 381A). See also L.J. McBride and M.H. Cruthers, Tetrahedron Letters, 24, 245 (1983).
The reagents used in the following examples include trichloroethylene 2-propanol tripropylamine (TPrA) Ru(bpy) 3 Cl2.6H 2 0, Ru(phen) 3 C1 2 0, ethyl alcohol (200 proof), Al(NO3)3.9H 2 0, K 2 Cr 2 0 7 NaH 2
PO
4 and tris(hydroxymethyl) aminomethane and were used as received without purification.
Bisphosphonic acid H 2 0 3
P(CH
2 4
PO
3
H
2
(C
4 BPA), and 4mercaptobutylphosphonic acid (MBPA) were synthesized in accordance with the techniques taught by Mallouk et al, 115, 11855 (1993). The assay buffer for ECL experiments contained 0.13 M TPrA and 0.19 M phosphate buffer, prepared by dissolving TPrA into a NaH 2
PO
4 solution and adjusting the pH to 7 with 1 M NaOH.
Deionized water from a Millipore Milli-Q (18 Mn-cm) system was used to prepare all aqueous solutions and to rinse the electrode surface.
TEM Sample Preparation.
TEM samples were prepared by coating Au on a Formvar film on a #400 Cu grid with a vacum evaporator (Edwards 306), -18- WO 96/06946 PCT/US95/10630 fabricating the A1 2
(C
4 BP) film on Au following the procedure described above and then immobilizing DNA on the A1 2
(C
4
BP)
film. A transmission electron microscope (JEOL 100CX) at KV was used to image the Au substrate, the A1 2
(C
4 BP) film and the immobilized DNA.
-19- WO 96/06946 PCTIUS95/10630 Example 1 Electrocenerated Chemiluminescent Detection of Immobilized ds-DNA using A Ruthenium Label.
Calf thymus ds-DNA was immobilized on the surface of an A1 2
(C
4 BP) film by immersing the film in a solution of DNA (1.9 mM in nucleotide phosphate, NP) for 4 h (Figs. 1 and 2).
The film was then rinsed three times with 4-mL portions of deionized water and then immersed for 4 h in either an aqueous 0.56 mM Ru(phen) 3 Cl 2 solution or a 0.12 mM Ru(phen) 3 (C10 4 2 solution in MeCN. Ru(phen) 3 2 associates with ds-DNA and can be detected through its electrogenerated chemiluminescence (ECL). Alternatively, the film could be soaked in a mixed ds- DNA (1.9 mM NP) and Ru(phen) 3
C
2 1 (0.12mM) solution for 4 h to produce the adsorbed layer.
ECL was produced by scanning the potential of the electrode following film formation, DNA adsorption, and Ru(phen) 3 2+ association, from 0 to 1.6 V vs. a saturated calomel electrode (SCE) while it was immersed in a solution of 0.19 M phosphate buffer (pH 7) containing 0.13 M tri-npropylamine (TPrA). Typical ECL transients, detected with a single-photon-counting apparatus, are shown in Figures 3A-3C.
Emission arises from the energetic electron-transfer reaction between electrogenerated Ru(phen) 3 3 and an intermediate in the oxidation of TPrA: DNA-Ru(phen) 3 2 (ads) e DNA-Ru(phen) 3 3 [1]
CH
3
CH
2
CH
2 -N-Pr 2 e CH 3 CHCHNPr 2 [2]
CH
3
CH
2 CH,NPr2 CH 3 CH,CHNPr 2 H [3] WO 96/06946 PCT/US95/10630 DNA-Ru(phen) 3+ CH 3
CH
2 CHNPr 2 -+DNA-Ru(phen) 3 2
*+CH
3
CH
2 CHNPr2 [4] DNA-Ru(phen) 3 2 DNA-Ru(phen) 3 2 hv The emission intensity decreased on a second scan and none was seen on a third, suggesting loss of Ru(phen) 3 3 from the film and diffusion into the bulk solution.
In a control experiment, an electrode with a film of Al2(C 4 BP) that had not been treated with DNA was soaked for 4 h in either an aqueous 0.56 mM Ru(phen) 3 2 or a 0.12 mM Ru(phen) 3 2+ in MeCN solution and then rinsed with MeCN and water. This electrode showed no ECL emission upon potential sweep in the same TPrA solution described above, demonstrating the adsorption of Ru(phen) 3 2+ on the A21(C 4 BP) film does not occur. The ability to generate Ru(phen) 3 electrochemically in this ECL experiment demonstrates that the A1 2
(C
4 BP) film and the DNA layer do not prevent heterogeneous electron-transfer reactions.
To obtain further evidence for Al,(C 4 BP) film formation and DNA immobilization, experiments were undertaken with a gold-coated quartz crystal and a quartz crystal microbalance (QCM). The gold was repeatedly treated with hot chromic acid and then rinsed with water and EtOH until the surface was hydrophilic, as indicated by contact angle measurements. The crystal frequency was then measured in air during different stages of Al,(C4BP) film formation, after DNA adsorption, and after Ru(phen) 3 2+ association. The film was rinsed after each step with deionized water and dried in a -21- WO 96/06946 WO 9606946PCTIUS95/10630 stream of N 2 before measurement of the frequency. Results are shown in Table 1.
-22- WO 96/06946 PCT/US95/10630 Table 1. Frequency and Mass Changes on a QCM Plate for Film Growth, DNA Immobilization, and Ru(phen)2+ Binding.
After immersion in: AfV (Hz) Am (nc) 1 0 9 r h (mol/cm 2 MBPAb -70 137 1 Al(NO 3 3 -27 53 1'
C
4 BPAd -145 283 2 A .(NO 3 3 c -25 49 V1 ds-DNAe -24 47 0.3i Ru(phen) 2 +f -18 35 0.1 a Immersions were sequential in order given from top to bottom; bare surface was gold; bare crystal frequency, 6.011329 MHz.
b 0.5 mM MBPA in EtOH for 24 h.
c 5 mM aq. Al(NO 3 3 for 4 h.
d 5 mM phosphoric acid for 4 h.
e Calf thymus DNA (3.8 mM NP) for 4 h.
f 0.24 mM Ru(phen) 3 2+ in MeCN for 4 h.
9 The variation and drift of the signal over the series of measurements was about 1 Hz.
h Assuming roughness factor for gold of 2 (total surface area, 0.6 cm 2 For comparison, for a close-packed monolayer of MBPA, F 0.6 x 10- 9 mol/cm 2 Assuming an Al(H20) 3 3+ until adsorbed.
Corresponding to moles of nucleotide phosphate (NP) per cm 2 Clearly, the crystal frequency decreases as the A1 2
(C
4 BP) film forms and DNA and Ru(phen) 3 2+ are adsorbed on the surface, showing an increase of mass on the crystal during the different stages. The mass change, Am, can be related to the -23- WO 96/06946 PCT/US95/10630 frequency change, Af, by the Sauerbrey equation: Am -(AJ-I/2FoAf where Fo is the fundamental frequency of the unloaded crystal (6 MHz), A is the electrode area (0.159 cm 2 p, is the density of quartz (2.65 g/cm 3 and Aq is the shear modulus of quartz (2.95 x 10" dyne/cm 2 With these constants, Am (ng) -1.95 Af (Hz) The mass changes calculated in this way are also given in Table 1. These can be converted to approximate surface concentrations, r, assuming a roughness factor of 2 total surface area of both sides of the quartz crystal of 0.6 cm2). ECL could also be detected from both gold surfaces of the quartz crystal, when used as a substrate for A1 2
(C
4 BP) film formation, DNA adsorption and Ru(phen) 3 2 association and then scanned in the TPrA solution.
The electrode surface can be designed with immobilized DNA without adsorbing a detector molecule, Ru(phen) 3 2 A ds-DNA on the surface can be detected by electrogenerated chemiluminescence of associated Ru(phen) 3 2 Single-stranded DNA can also be immobilized on the A1 2
(C
4
BP)
film surface and then hybridized with complementary DNA in solution with detection of the ds-DNA produced by ECL.
-24- WO 96/06946 PCT/US95/10630 Example 2 Single-strand DNA immobilization and hybridization.
X-1 tagged ss-DNA labeled with Ru(bpy) 3 was immobilized on an aluminum phosphate film of the present invention by immersing the film in the DNA solution (Fig. 4A).
The amount of immobilized DNA-Ru(bpy) 3 2 on the surface was determined by ECL resulting from the oxidation of Ru(bpy) 3 2 and TPrA in a solution.
Untagged X-lc ss-DNA was immobilized on an aluminum phosphate of the present invention. The X-lc ss-DNA containing film was incubated in a complementary strand X-1 tagged ss-DNA solution at 60 0 C for 5 min and then cooled to room temperature gradually; during this cooling the ss-DNA hybridized with the complementary strand DNA (Fig. 4B). The hybridized DNA-Ru(bpy) 3 2+ on the film was detected by ECL as described above.
Poly(dA) was immobilized on an aluminum phosphate film of the present invention by soaking the film in a poly(dA) solution. After the immobilization, poly(dT) was hybridized with poly(dA) to produce poly(dA) poly(dT) ds-DNA on the surface by incubating the film in a poly(dT) solution at 70 0 C for 5 min and then cooled to the room temperature gradually (Fig. 4C). To intercalate Ru(phen) 3 2 into the ds- DNA (poly(dA)*poly(dT)), the A1 2
(C
4 BP)/poly(dA) poly(dT) film was treated with a Ru(phen) 3 2+ solution. The hybridized poly(dA)*poly(dT)-Ru(phen) 3 2 on the surface was determined by ECL based on the oxidation of Ru(phen) 3 2 and TPrA in the WO 96/06946 PCT/US95/10630 solution.
Example 3 Immobilization and Detection of 30 bp ss-DNA.
Immobilized On Aluminum Phosphate Film.
The aluminum phosphate film, prepared as described above was immersed in a 1.38 CM solution of X-1 30 bp ss-DNA (tagged with Ru(bpy) 3 2 for -2 h. This was employed as a working electrode for an ECL experiment in a 0.19 M phosphate buffer (pH 7) containing 0.13 M TPrA. Cyclic voltammograms and emission transients were obtained by scanning the potential of the electrode from 0 to 1.6 V vs, a saturated calomel electrode (SCE). A representative voltammogram and emission detected with a single-photon-counting system are shown in Figures 5A-5C. The broad oxidation was at 1.2 V and a small reduction wave at -0.35 V observed in the voltammogram (Fig. 5A) arise from the oxidation of TPrA, Ru(bpy) 3 2+ and the Au substrate and the reduction of the oxide of Au. The ECL emission from the A12(C 4 BP)/X-1 ss-DNA- Ru(bpy) 3 2 electrode (Fig. 5B) demonstrates that the X-1 30 bp ss-DNA-Ru(bpy) 3 2 was immobilized on the film. The decay of the light intensity as a function of time was also investigated with the single-photon-counting system. The light intensity detected by the photomultiplier tube, when the potential was stepped from 0 to 1.50 V, decreased with time (Fig. The decay of intensity with time suggests desorption of ss-DNA-Ru(bpy) 3 2 from the electrode surface or -26- WO 96/06946 PCT/US95/10630 irreversible decomposition of the emitter. Emission results from the energetic electron-transfer reaction between electrogenerated Ru(bpy)3 3 and an intermediate in the oxidation of TPrA: DNA-Ru(bpy) 3 2 (ads) DNA-Ru(bpy) 3 3 e [6]
CH
3
CHCH
2 NPr 2 e CH 3
CH
2
CH
2 Pr2 [7]
CH
3
CHHH
2 Pr2+ CH 3
CH
2 CHNPr 2 H+ [8] DNA-Ru (bpy) 3 3
++CH
3
CH
2 CHNPr 2 DNA-Ru (bpy) 3 2++CH 3
CH
2 CHNPr 2 [9] DNA-Ru(bpy) 3 2 DNA-Ru(bpy) 3 2 hv No ECL emission was observed from a film prepared by immersing it in solution of unlabeled ss-DNA: 1.38 AM 30 bp ss-DNA or a 0.37 AM X-lc 30 bp ss-DNA solution (Fig. A control experiment with the aluminum phosphate film immersed in a 304 nM Ru(bpy) 3 2+ solution for 4 h shows a negligible ECL signal, indicating that Ru(bpy) 3 2+ does not adsorb on the film and oxidize.
Example 4 Detection of 30 bp ss-DNA Hybridized to Complementary SS-DNA Taqqed With A Ruthenium Label.
After the immobilization of unlabeled X-lc 30 bp ss- DNA on the A1 2
(C
4 BP) film, the film was immersed in a 1.38 AM complementary strand ss-DNA (tagged with Ru(bpy) 3 (X-i 30 bp ss-DNA-Ru(bpy) 3 2 solution. The film in the solution was gradually heated to 60 0 C in water bath, incubated at 60 0 C for -27-
F_
WO 96/06946 PCT/US95/10630 min. and then slowly cooled to room-temperature, during which the X-l ss-DNA-Ru(bpy) 3 2 was hybridized with the complementary strand X-lc ss-DNA on the surface as illustrated in Fig. 4B. The film with hybridized DNA was employed as the working electrode in an ECL cell as described above. The ECL emission from the film was observed as shown in Fig. 7A.
However, when X-l ss-DNA, rather than X-lc ss-DNA, was immobilized on the film and followed by the same hybridization procedure as described above by incubating the film in the X-l ss-DNA-Ru(bpy) 3 2 solution, heating to 600C, and then cooling to room-temperature, no obvious ECL emission was evident as shown in Fig. 7B. This demonstrates that the ECL emission in Fig. 7A arises from the hybridization of immobilized X-lc ss- DNA with X-i ss-DNA-Ru(bpy) 3 2 in the solution. The emission again results from the oxidation of Ru(bpy) 3 2 +-tagged hybridized ss-DNA and TPrA in the solution as described by Eqs. In this experiment the A1 2
(C
4 BP) film should be incubated in the X-i ss-DNA solution for a sufficiently long time (at least 4 h) to cover all possible Al (III) binding sites on the film with the X-1 ss-DNA before the Al 2
(C
4 BP)/X-1 ss-DNA electrode is exposed to the X-i ss-DNA- Ru(bpy)3 2 It is preferred to cover all A13+ adsorption sites to avoid emission from the film/X-1 ss-DNA/X-1 ss-DNA- Ru(bpy) 3 2 arising from some immobilization of ss-DNA- Ru(bpy) 3 2 -28-
I
WO 96/06946 PCT/US95/10630 Example Detection of poly(dA) Hybridized to poly(dT) using a Ruthenium Label.
The aluminum phosphonate film, prepared as described above, was immersed in a 21 AM poly(dA) solution for -4 h, then in a 0.24 mM Ru(phen) 3 2+ solution for -4 h. When the Al 2
(C
4 BP)/poly(dA)/Ru(phen) 3 2 film was employed as a working electrode in a solution of 0.19 M phosphate buffer (pH 7) containing 0.13 M TPrA, no ECL emission was observed (Fig.
8A). This is consistent with the lack of association of Ru(phen) 3 2 with ss-DNA. However, a film of poly(dA) hybridized with only poly(dT) to form ds-DNA did produce ECL.
This film, formed by immersion in the poly(dA)solution, was incubated in a 38 AM poly(dT) solution (gradually heated to 70 0 C in a water bath, incubated at 70 0 C for 5 min and then slowly cooled to room temperature). It was then treated with a 0.24 mM Ru(phen) 3 2 aqueous solution and used as a working electrode in the TPrA-containing phosphate buffer for ECL investigation. ECL emission was observed as shown in a representative emission transient (Fig. 8B), demonstrating that poly(dT) in the solution hybridized with the poly(dA) on the surface to produce a ds-DNA [poly(dA)*poly(dT] and Ru(phen) 3 2 intercalated with the ds-DNA as shown in Fig. 4c.
These examples show that Ru(phen) 3 2 only intercalates with ds-DNA [poly(dA)*poly(dT], but not with ss- DNA (poly(dA)). Intercalation of Ru(phen) 3 2+ with ss-DNA and ds-DNA, ECL emission was measured from a 43 nM Ru(phen) 3 2+ -29- WO 96/06946 WO 9606946PCT/US95/10630 solution, a 43 nm Ru(phen) 3 2 containing 57 AM nucleotide phosphate (CNP]) of calf thymus ss-DNA and a 43 nM Ru(phen) 3 2 containing 33 A~M [NP] of calf thymus ds-DNA with a QPCR analyzer. Results are given in Table 2, II WO 96/06946 PCT/US95/10630 Table 2 ECL of Solutions of 43 nM Ru(phen) 3 2 with ss-DNA and ds-DNA Solution I II2 III2 Ru(phen) 3 alone ss-DNA+Ru(phen) 3 2 ds-DNA+Ru(phen) 3 2 Cone. NP(AM) 0 57 33 ECL(cts/s) 10068+23 10052+12 7779+268 1 Ratio of moles of nucleotide phosphate (NP) of ss-DNA to Ru(phen) 3 2+ 1.3 x 104 b Ratio of moles of nucleotide phosphate (NP) of ds-DNA to Ru(phen) 3 2 7.7 x 103 indicating that the ECL emission decreased after ds-DNA was added to the Ru(phen) 3 2 solution. A negligible change, however, in the ECL signal was shown when ss-DNA was added, further demonstrating that Ru(phen) 3 2 only intercalates with ds-DNA, but not with ss-DNA.
A control experiment in which a film, after the immobilization of poly(dA), was incubated in a 21 gM poly(dA) or a 46 gM poly(dC) solution instead of poly(dT) (70 0 C for min then cooled to room-temperature) and then treated with Ru(phen) 3 2 4 for -2 h produces'no ECL emission. This indicates that the Al2(C 4 BP)/poly(dA) electrode can distinguish a complementary strand of poly(dT) DNA from non-complementary ones.
-31-
I-
WO 96/06946 PCTIUS95/10630 Example 6 TEM Images of the film and calf thymus ds-DNA.
Samples, prepared by coating Au on a Formvar film on a #400 Cu grid with a vacuum evaporator fabricating the P" fabricating the aluminum phosphate film on the Au as described above, and then immobilizing DNA on the A1 2
(C
4 BP) film by immersing the film in a 1.65 mM [NP) of calf thymus ds-DNA for 4 h, were imaged with a transmission electron microscope (TEM) at 80 KV. As shown in Figs. 9A-9C the featureless Au substrate (Fig. 9A) shows formation of crystalline islands of A(BP) film (Fig. 9B) and clumps of DNA (Fig. 9C). The film (Fig. 10A) was then treated with either 1.65 mM [NP] calf thymus ds-DNA (Fig. or an identical solution of ds-DNA that had been subjected to sonication for 6 h (Fig. 10C). The results indicate that h e results indicate that smaller clumps of DNA are adsorbed on the film after sonication.
A further embodiment of the invention is shown in Figs. 11A and 11B. A sensor surface having a multilayer film with bonding groups is provided with a complete set of oligonucleotide probes using similar techniques described above for adsorbing ds-DNA and for SS-DNA. See Fig. 11A. The sensor surface of Fig. 11A is contacted with DNA to be sequenced. The above disclosed ECL procedures are then used to recognize zones with a complementary sequence. (Fig. 1B).
When chips are used, different types of ss-DNA that make up a test sequence are attached to the surface of a chip to make an array. The chip array is then exposed to the -32- WO 96/06946 PCT/US95/10630 sample solution to be sequenced, with formation of ds-DNA at the appropriate location being recognized by the ECL approach.
Although the invention has been described in conjunction with the specific embodiments, it is evident that many alternatives and variations will be apparent to those skilled in the art in light of the foregoing description.
Accordingly, the invention is intended to embrace all of the alternatives and variations that fall within the spirit and scope of the appended claims.
-33- WO 96/06946 PCT/US95/10630 SEQUENCE LISTING GENERAL INFORMATION: APPLICANTS: Allen J. Bard and Xia-Hong Hu (ii) TITLE OF THE INVENTION: BIOSENSOR FOR AND METHOD OF ELECTROGENERATED
CHEMILUMINESCENT
DETECTION OF NUCLEIC ACID ADSORBED TO A SOLID
SURFACE
(iii) NUMBER OF SEQUENCES: 3 (iv) CORRESPONDENCE
ADDRESS:
ADDRESSEE: Morgan Finnegan STREET: 1299 Pennsylvania Ave., N.W., Suite 960 CITY: Washington STATE: District of Columbia ZIP CODE: 20004 COMPUTER READABLE FORM: MEDIUM TYPE: Diskette, 3.50 inch, 1.44 Mb storage COMPUTER: IBM COMPATIBLE OPERATING SYSTEM: MS-DOS SOFTWARE: WordPerfect 5.1 (vi) CURRENT APPLICATION
DATA:
APPLICATION NUMBER: 08/296,630 FILING DATE: 08/26/94 CLASSIFICATION:
N/A
(vii) PRIOR APPLICATION DATA: N/A (viii) ATTORNEY/AGENT
INFORMATION:
NAME: Michael S. Marcus REGISTRATION NUMBER: 31,727 REFERENCE/DOCKET NUMBER: 23247001 (ix) TELECOMMUNICATION
INFORMATION:
TELEPHONE: (202) 857-7887 TELEFAX: (202) 857-7929 INFORMATION FOR SEQ ID NO: 1: SEQUENCE
CHARACTERISTICS:
LENGTH: TYPE: nucleic acid STRANDEDNESS: single TOPOLOGY: linear 34
F_
WO 96/06946 PCT/US95/10630 (ii) MOLECULE TYPE: (iii) HYPOTHETICAL:
NO
(iv) ANTI-SENSE:
NO
FRAGMENT TYPE: LAMBDA (vi) ORIGINAL SOURCE:
ORGANISM:
STRAIN:
INDIVIDUAL ISOLATE: DEVELOPMENTAL
STAGE:
HAPLOTYPE:
TISSUE TYPE: CELL TYPE: CELL LINE:
ORGANELLE:
(vii) IMMEDIATE
SOURCE:
LIBRARY:
CLONE:
(viii) POSITION IN GENOME: CHROMOSOME SEGMENT: N/A MAP POSITION: N/A UNITS: N/A (ix) FEATURE:
NAME/KEY:
LOCATION: N/A IDENTIFICATION
METHOD:
OTHER INFORMATION:
N/A
PUBLICATION INFORMATION:
AUTHORS:
TITLE:
JOURNAL:
VOLUME:
ISSUE:
PAGES:
DATE:
DOCUMENT NUMBER: FILING DATE: PUBLICATION DATE: RELEVANT RESIDUES In SEQ ID NO: 1: (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1: GAAAATGTGC TGACCGGACA TGAAAATGAG INFORMATION FOR SEQ ID NO: 2: 35
I
WO 96/06946 PCT/US95/10630 SEQUENCE
CHARACTERISTICS:
LENGTH:
TYPE:
STRANDEDNESS: single TOPOLOGY: linear (ii) MOLECULE
TYPE:
(iii) HYPOTHETICAL:
NO
(iv) ANTI-SENSE:
N/A
FRAGMENT TYPE: LAMBDA (vi) ORIGINAL SOURCE:
ORGANISM:
STRAIN:
INDIVIDUAL ISOLATE: DEVELOPMENTAL
STAGE:
HAPLOTYPE:
TISSUE TYPE: CELL TYPE: CELL LINE:
ORGANELLE:
(vii) IMMEDIATE SOURCE:
LIBRARY:
CLONE:
(viii) POSITION IN GENOME: CHROMOSOME SEGMENT: N/A MAP POSITION:
N/A
UNITS: N/A (ix) FEATURE:
NAME/KEY:
LOCATION: N/A IDENTIFICATION
METHOD:
OTHER INFORMATION:
N/A
PUBLICATION
INFORMATION:
AUTHORS:
TITLE:
JOURNAL:
VOLUME:
ISSUE:
PAGES:
DATE:
DOCUMENT
NUMBER:
FILING DATE: PUBLICATION
DATE:
RELEVANT RESIDUES In SEQ ID NO: 2: 36 WO 96/06946 WO 9606946PCTJUS95/10630 (Xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2: CTCATTTTCA TGTCCGGTCA GCACATTTTC 37

Claims (28)

1. A method of detecting nucleic acids comprising: a. forming a sensor surface bearing a film having metallic centers; b. adsorbing at least one nucleic acid onto to said metal centers; c. reacting nucleic acid adsorbed to said film with a luminescent metal label; and d. detecting the nucleic acid metal label chelates formed in step via electrogenerated chemiluminescence of said chelates.
2. The method of claim 1, wherein the nucleic acid of step is double-stranded.
3. The method of claim 1, wherein the nucleic acid of step is single-stranded.
4. The method of claim 3, wherein step further comprises binding the single-stranded nucleic acid adsorbed to the film, to a complementary single-stranded nucleic acid sequence.
The method of claim 1, wherein said electrogenerated chemiluminescence arises from a reaction of an electrogenerated metal label in the nucleic acid -metal label 38 WO 96/06946 PCT/US95/10630 chelate and a suitable coreactant.
6. The method of claim 5, wherein said electrogenerated metal label is produced via emission from the sensor which is an electrode.
7. A method of detecting nucleic acids comprising: a. forming an electrode by adsorbing at least one nucleic acid onto said electrode; b. reacting nucleic acid adsorbed to said electrode with a luminescent label; and c. detecting the nucleic acid label formed in step via electrogenerated chemiluminescence.
8. The method of claim 7, wherein the nucleic acid of step is double-stranded.
9. The method of claim 7, wherein the nucleic acid of step is single-stranded.
The method of claim 8, wherein step further comprises binding the single-stranded nucleic acid adsorbed to the electrode, to a complementary single-stranded nucleic acid sequence.
11. The method of claim 7, wherein said electrogenerated chemiluminescence arises from a reaction of an 39 WO 96/06946 PCT/US95/10630 electrogenerated metal label in the nucleic acid metal label chelate and a suitable coreactant.
12. The method of claim 11, wherein said electrogenerated metal label is produced via emission from the electrode.
13. An aluminum alkanebisphosphonate biosensor comprising: a substrate and a first metallic layer; and an aluminum alkanebisphosphonate layer forming (Al) metallic centers.
14. A biosensor according to claim 13, wherein said biosensor further includes single-strand DNA immobilized to said aluminum centers.
A biosensor according to claim 14, wherein said DNA is labelled with and an osmium or ruthenium moiety.
16. A biosensor according to claim 13, wherein said biosensor further includes double-strand DNA immobilized to said aluminum centers.
17. A biosensor according to claim 16, wherein said DNA is labelled with an osmium or ruthenium moiety. 40 41
18. A method of preparing a biosensor for nucleic acid, comprising: a) treating a silicon wafer to form a chromium layer and juxtaposed gold layer; b) contacting said layered wafer with an anchoring agent; and c) immersing the product of step b) alternately in Al(N0 3 3 bisphosphonic (H 2 0 3 P(CH 2 4 PO 3 H 2 and Al(N0 3 3 aqueous solutions.
19. A biosensor comprising: an electrode substrate, adsorbed ss-DNA or ds-DNA immobilised on said electrode, and a detectable label on said ss-DNA or ds-DNA wherein the detectable label is capable of being oxidised or reduced.
A biosensor according to claim 19, wherein said DNA is labelled with an osmium or ruthenium moiety or a luminescent label.
21. A method of detecting nucleic acids, substantially as hereinbefore described with reference to any one of the Examples.
22. An aluminum alkanebisphosphonate biosensor, substantially as hereinbefore S described with reference to any one of the Examples. 0:
23. An aluminum alkanebisphosphonate biosensor, substantially as hereinbefore described with reference to the accompanying drawings.
24. A method of preparing a biosensor, substantially as hereinbefore described 0 20 with reference to any one of the Examples.
A method of preparing a biosensor, substantially as hereinbefore described with reference to the accompanying drawings.
26. A biosensor, substantially as hereinbefore described with reference to any one of the Examples. S 25
27. A biosensor, substantially as hereinbefore described with reference to the accompanying drawings. 0 Dated
28 January, 1999 Igen, Inc. Patent Attorneys for the Applicant/Nominated Person SPRUSON FERGUSON [N:\LIBFF]O348:SAK
AU34103/95A 1994-08-26 1995-08-25 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface Ceased AU703344B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU36767/99A AU3676799A (en) 1994-08-26 1999-06-25 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to solid surface

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29663094A 1994-08-26 1994-08-26
US08/296630 1994-08-26
PCT/US1995/010630 WO1996006946A1 (en) 1994-08-26 1995-08-25 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU36767/99A Division AU3676799A (en) 1994-08-26 1999-06-25 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to solid surface

Publications (2)

Publication Number Publication Date
AU3410395A AU3410395A (en) 1996-03-22
AU703344B2 true AU703344B2 (en) 1999-03-25

Family

ID=23142843

Family Applications (1)

Application Number Title Priority Date Filing Date
AU34103/95A Ceased AU703344B2 (en) 1994-08-26 1995-08-25 Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface

Country Status (5)

Country Link
EP (1) EP0777741A4 (en)
JP (1) JPH10509025A (en)
AU (1) AU703344B2 (en)
CA (1) CA2198489A1 (en)
WO (1) WO1996006946A1 (en)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786141A (en) * 1994-08-26 1998-07-28 Bard; Allen J. Electrogenerated chemiluminescence labels for analysis and/or referencing
US6673533B1 (en) 1995-03-10 2004-01-06 Meso Scale Technologies, Llc. Multi-array multi-specific electrochemiluminescence testing
US6140045A (en) 1995-03-10 2000-10-31 Meso Scale Technologies Multi-array, multi-specific electrochemiluminescence testing
US6207369B1 (en) 1995-03-10 2001-03-27 Meso Scale Technologies, Llc Multi-array, multi-specific electrochemiluminescence testing
US6066448A (en) * 1995-03-10 2000-05-23 Meso Sclae Technologies, Llc. Multi-array, multi-specific electrochemiluminescence testing
US6319670B1 (en) 1995-05-09 2001-11-20 Meso Scale Technology Llp Methods and apparatus for improved luminescence assays using microparticles
US7014992B1 (en) 1996-11-05 2006-03-21 Clinical Micro Sensors, Inc. Conductive oligomers attached to electrodes and nucleoside analogs
FR2762013B1 (en) 1997-04-09 1999-06-04 Cis Bio Int DETECTION SYSTEMS FOR NUCLEIC ACID HYBRIDIZATION, PREPARATION METHOD THEREOF AND USES THEREOF
US6289229B1 (en) 1998-01-20 2001-09-11 Scimed Life Systems, Inc. Readable probe array for in vivo use
US6942771B1 (en) 1999-04-21 2005-09-13 Clinical Micro Sensors, Inc. Microfluidic systems in the electrochemical detection of target analytes
WO2001007665A2 (en) 1999-07-26 2001-02-01 Clinical Micro Sensors, Inc. Sequence determination of nucleic acids using electronic detection
WO2001042508A2 (en) * 1999-12-09 2001-06-14 Motorola, Inc. Methods and compositions relating to electrical detection of nucleic acid reactions
US6518024B2 (en) 1999-12-13 2003-02-11 Motorola, Inc. Electrochemical detection of single base extension
US6824669B1 (en) 2000-02-17 2004-11-30 Motorola, Inc. Protein and peptide sensors using electrical detection methods
US6706479B2 (en) * 2000-10-05 2004-03-16 Virginia Tech Intellectual Properties, Inc. Bio-chip, photoluminescent methods for identifying biological material, and apparatuses for use with such methods and bio-chips
WO2005016115A2 (en) 2003-01-23 2005-02-24 Montana State University Biosensors utilizing dendrimer-immobilized ligands and their use thereof
DE602004023604D1 (en) 2003-05-13 2009-11-26 Trustees Boston College ELECTROCATALYTIC NUCLEIC ACID HYBRIDIZATION DETECTION
US7741033B2 (en) * 2003-05-13 2010-06-22 Trustees Of Boston College Electrocatalytic nucleic acid hybridization detection
JPWO2006075497A1 (en) * 2004-12-21 2008-06-12 国立大学法人京都大学 Probe unit, nucleotide region identification apparatus, and nucleotide region identification method
ES2636664T3 (en) 2008-09-02 2017-10-06 The Governing Council Of The University Of Toronto Nanostructured microelectrodes and biodetection devices that incorporate them
ES2704685T3 (en) 2011-01-11 2019-03-19 Governing Council Univ Toronto Method for protein detection
US9580742B2 (en) 2011-03-10 2017-02-28 Shana O. Kelley Diagnostic and sample preparation devices and methods
CN117491623A (en) 2015-08-20 2024-02-02 豪夫迈·罗氏有限公司 Particle-based immunoassays using pegylated analyte-specific binding agents
CN108780092A (en) 2016-03-07 2018-11-09 豪夫迈·罗氏有限公司 The detection of anti-p53 antibody
EP3577460B1 (en) 2017-02-02 2021-01-20 Roche Diagnostics GmbH Immunoassay using at least two pegylated analyte-specific binding agents
CN111936522A (en) 2018-04-18 2020-11-13 豪夫迈·罗氏有限公司 Novel anti-thymidine kinase antibodies
WO2020043868A1 (en) 2018-08-31 2020-03-05 F. Hoffmann-La Roche Ag Thymidine kinase (tk-1) in prognostic indices for dlbcl
EP4004555A1 (en) 2019-07-22 2022-06-01 F. Hoffmann-La Roche AG S100a6 as blood biomarker for the non-invasive diagnosis of endometriosis
WO2021013784A1 (en) 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a8 as blood biomarker for the non-invasive diagnosis of endometriosis
BR112022000172A2 (en) 2019-07-22 2022-02-22 Hoffmann La Roche Methods for assessing whether a patient has endometriosis, for selecting a patient for therapy, and for monitoring a patient
CN114144674A (en) 2019-07-22 2022-03-04 豪夫迈·罗氏有限公司 Substance P as a blood biomarker for the non-invasive diagnosis of endometriosis
JP7315781B2 (en) 2019-07-22 2023-07-26 エフ. ホフマン-ラ ロシュ アーゲー S100A12 as a blood biomarker for non-invasive diagnosis of endometriosis
EP4058459A1 (en) 2019-11-15 2022-09-21 F. Hoffmann-La Roche AG Derivatization of beta-lactam antibiotics for massspec measurements in patient samples
CN111272742B (en) * 2020-03-06 2022-11-08 安徽大学 Electrochemiluminescence sensor based on metal organic gel composite material and metal organic framework and preparation and detection methods thereof
WO2022090455A1 (en) 2020-11-02 2022-05-05 F. Hoffmann-La Roche Ag Sars-cov-2 nucleocapsid antibodies
WO2022207628A1 (en) 2021-03-30 2022-10-06 F. Hoffmann-La Roche Ag Scf as blood biomarker for the non-invasive diagnosis of endometriosis
CN117099001A (en) 2021-04-01 2023-11-21 豪夫迈·罗氏有限公司 PSP94 as blood biomarker for non-invasive diagnosis of endometriosis
EP4341700A1 (en) 2021-05-17 2024-03-27 F. Hoffmann-La Roche AG Sfrp4 as blood biomarker for the non-invasive diagnosis of adenomyosis
WO2023072904A1 (en) 2021-10-26 2023-05-04 F. Hoffmann-La Roche Ag Monoclonal antibodies specific for sars-cov-2 rbd
WO2023131594A1 (en) 2022-01-05 2023-07-13 F. Hoffmann-La Roche Ag Derivatization of compounds in patient samples for therapeutic drug monitoring (tdm)
WO2023247752A1 (en) 2022-06-23 2023-12-28 F. Hoffmann-La Roche Ag Method for diagnosing endometriosis and for classifying the stage of endometriosis
WO2024017983A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Meteorin-like protein (metrnl) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome
WO2024017982A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Leukotriene a4 hydrolase (lta4h) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome
WO2024017985A1 (en) 2022-07-22 2024-01-25 F. Hoffmann-La Roche Ag Fibroblast growth factor binding protein 1 (fgfbp1) as (blood) biomarker for the diagnosis of polycystic ovarian syndrome
CN115414930B (en) * 2022-08-26 2023-10-31 重庆医科大学 Ru(bpy) 32+ Anode or cathode coreactant and method for producing same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1258580A (en) * 1967-12-28 1971-12-30
US5238808A (en) * 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
US5124022A (en) * 1989-08-23 1992-06-23 Aluminum Company Of America Electrolytic capacitor and method of making same
US5019343A (en) * 1989-12-15 1991-05-28 W. R. Grace & Co.-Conn. Control of corrosion in aqueous systems using certain phosphonomethyl amines
US5846708A (en) * 1991-11-19 1998-12-08 Massachusetts Institiute Of Technology Optical and electrical methods and apparatus for molecule detection

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ANAL. CHEM, 66(6) PP.769-777(1994) *

Also Published As

Publication number Publication date
EP0777741A1 (en) 1997-06-11
CA2198489A1 (en) 1996-03-07
EP0777741A4 (en) 1999-01-13
WO1996006946A1 (en) 1996-03-07
AU3410395A (en) 1996-03-22
JPH10509025A (en) 1998-09-08

Similar Documents

Publication Publication Date Title
AU703344B2 (en) Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to a solid surface
Xu et al. Immobilization and hybridization of DNA on an aluminum (III) alkanebisphosphonate thin film with electrogenerated chemiluminescent detection
US6127127A (en) Monolayer and electrode for detecting a label-bearing target and method of use thereof
US6096500A (en) Multi-label complex for enhanced sensitivity in electrochemiluminescence assay
US7160678B1 (en) Compositions for the electronic detection of analytes utilizing monolayers
US7829275B2 (en) Light addressable electrochemical detection of duplex structures
US20090036315A1 (en) Device and methods for detecting and quantifying one or more target agents
US6387625B1 (en) Monolayer and electrode for detecting a label-bearing target and method of use thereof
AU6337696A (en) Electrochemical detection of nucleic acid hybridization
WO2007092552A2 (en) Device and methods for detecting and quantifying one or more target agents
KR100459394B1 (en) Electrochemiluminescence detection method for a nucleic acid using an intercalator
US20100279278A1 (en) Methods of detecting one or more bioterrorism target agents
AU3676799A (en) Biosensor for and method of electrogenerated chemiluminescent detection of nucleic acid adsorbed to solid surface
JP4706074B2 (en) Tripod-type functional interface molecules for immobilization of biomolecules and gene detection devices using them
WO2005042783A1 (en) Temperature-jump enhanced electrochemical detection of nucleic acid hybridization
Palchetti et al. Electrochemical adsorption technique for immobilization of single-stranded oligonucleotides onto carbon screen-printed electrodes
WONG Recent trends in DNA biosensing technologies
CA2471339A1 (en) Method and device for the quantitative electrical detection of analytes
CN116376552A (en) Monoatomic electrochemiluminescence probe and preparation method and application thereof
US20070077593A1 (en) Substrate as a ligate carrier
Zarei Development of Light-Addressable Electrode Arrays Towards the Application of DNA Hybridization Biosensor
JP4037766B2 (en) Target nucleic acid detection method and extension method, and assay kit
KR19990028484A (en) Electrochemical detection method of nucleic acid hybrids
Hintsche et al. Fully electrical microarrays
CN1375696A (en) Ultratrace DNA detecting method by means of nano microsphere amplificaltion technology and piezoelectric DNA biosensor